BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 3840949)

  • 41. Antitumor activity of an antibiotic identical with or closely related to xanthomycin A.
    Nishimura T; Kitajima J; Omura S; Tanaka N
    J Antibiot (Tokyo); 1981 Jul; 34(7):856-61. PubMed ID: 7287588
    [TBL] [Abstract][Full Text] [Related]  

  • 42. CC-1065 (NSC 298223), a novel antitumor agent that interacts strongly with double-stranded DNA.
    Li LH; Swenson DH; Schpok SL; Kuentzel SL; Dayton BD; Krueger WC
    Cancer Res; 1982 Mar; 42(3):999-1004. PubMed ID: 6174220
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Experimental antitumor activity of BMY-28175 a new fermentation derived antitumor agent.
    Schurig JE; Rose WC; Kamei H; Nishiyama Y; Bradner WT; Stringfellow DA
    Invest New Drugs; 1990 Feb; 8(1):7-15. PubMed ID: 2345072
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Quinone isomers of the WS-5995 antibiotics: synthetic antitumor agents that inhibit macromolecule synthesis, block nucleoside transport, induce DNA fragmentation, and decrease the growth and viability of L1210 leukemic cells more effectively than ellagic acid and genistein in vitro.
    Perchellet EM; Sperfslage BJ; Qabaja G; Jones GB; Perchellet JP
    Anticancer Drugs; 2001 Jun; 12(5):401-17. PubMed ID: 11395569
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Anthracyclines potentiate activity against murine leukemias L1210 and P388 in vivo and in vitro.
    Szmigielska-Kaplon A; Ciesielska E; Szmigiero L; Robak T
    Eur J Haematol; 2002 Jun; 68(6):370-5. PubMed ID: 12225395
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A fluorine-containing anthracycline (ME2303) as a new antitumor agent against murine and human tumors and their multidrug-resistant sublines.
    Tsuruo T; Yusa K; Sudo Y; Takamori R; Sugimoto Y
    Cancer Res; 1989 Oct; 49(20):5537-42. PubMed ID: 2790778
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Methotrexate analogues. 33. N delta-acyl-N alpha-(4-amino-4-deoxypteroyl)-L-ornithine derivatives: synthesis and in vitro antitumor activity.
    Rosowsky A; Bader H; Cucchi CA; Moran RG; Kohler W; Freisheim JH
    J Med Chem; 1988 Jul; 31(7):1332-7. PubMed ID: 3385730
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antitumor activity of derivatives of neplanocin A in vivo and in vitro.
    Hoshi A; Yoshida M; Iigo M; Tokuzen R; Fukukawa K; Ueda T
    J Pharmacobiodyn; 1986 Feb; 9(2):202-6. PubMed ID: 2423673
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Griseorubins, a new family of antibiotics with antimicrobial and antitumor activity. II. Biological properties and antitumor activity of the antibiotic complex griseorubin.
    Dornberger K; Berger U; Gutsche W; Jungstand W; Wohlrabe K; Härtl A; Knöll H
    J Antibiot (Tokyo); 1980 Jan; 33(1):9-12. PubMed ID: 7372557
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dynamics of antifolate transport via the reduced folate carrier and the membrane folate receptor in murine leukaemia cells in vitro and in vivo.
    Mauritz R; Peters GJ; Kathmann I; Teshale H; Noordhuis P; Comijn EM; Pinedo HM; Jansen G
    Cancer Chemother Pharmacol; 2008 Nov; 62(6):937-48. PubMed ID: 18283461
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Synthesis and antitumor activity of analogues of the antitumor antibiotic chartreusin.
    Takai M; Uehara Y; Beisler JA
    J Med Chem; 1980 May; 23(5):549-53. PubMed ID: 7381855
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Among substituted 9,10-dihydro-9,10-[1,2]benzenoanthracene-1,4,5,8-tetraones, the lead antitumor triptycene bisquinone TT24 blocks nucleoside transport, induces apoptotic DNA fragmentation and decreases the viability of L1210 leukemic cells in the nanomolar range of daunorubicin in vitro.
    Perchellet EM; Sperfslage BJ; Wang Y; Huang X; Tamura M; Hua DH; Perchellet JP
    Anticancer Drugs; 2002 Jul; 13(6):567-81. PubMed ID: 12172502
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Activity of a novel anthracenyl bishydrazone, 9,10-anthracenedicarboxyaldehyde Bis[(4,5-dihydro-1H-imidazol-2-yl)hydrazone] dihydrochloride, against experimental tumors in mice.
    Citarella RV; Wallace RE; Murdock KC; Angier RB; Durr FE; Forbes M
    Cancer Res; 1982 Feb; 42(2):440-4. PubMed ID: 7055799
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Models of preclinical studies of anthracyclines].
    Fizames C
    Pathol Biol (Paris); 1987 Jan; 35(1):41-8. PubMed ID: 3550611
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of aclacinomycin on cell survival and cell cycle progression of cultured mammalian cells.
    Traganos F; Staiano-Coico L; Darzynkiewicz Z; Melamed MR
    Cancer Res; 1981 Jul; 41(7):2728-37. PubMed ID: 6166368
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Modulation of the antitumor activity of 1-(4-amino-2-methyl-5-pyrimidinyl)methyl-3-(2-chloroethyl)-3-nitrosoure a by O(6)-methyl-2'-deoxyguanosine--a new inhibitor of O(6)-alkylguanine-DNA-alkyltransferase].
    Dederer LIu; Sokolova IS; Bakhmedova AA; Miniker TD; Mel'nik SIa; Gorbacheva LB
    Biokhimiia; 1995 Sep; 60(9):1521-9. PubMed ID: 8562657
    [TBL] [Abstract][Full Text] [Related]  

  • 57. (R,R)-2,2'-[1,2-ethanediylbis[imino(1-methyl-2,1-ethanediyl)]]- bis[5-nitro-1H-benz[de]isoquinoline-1,3-(2H)-dione] dimethanesulfonate (DMP 840), a novel bis-naphthalimide with potent nonselective tumoricidal activity in vitro.
    Kirshenbaum MR; Chen SF; Behrens CH; Papp LM; Stafford MM; Sun JH; Behrens DL; Fredericks JR; Polkus ST; Sipple P
    Cancer Res; 1994 Apr; 54(8):2199-206. PubMed ID: 8174127
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Triapine (3-aminopyridine-2-carboxaldehyde- thiosemicarbazone): A potent inhibitor of ribonucleotide reductase activity with broad spectrum antitumor activity.
    Finch RA; Liu M; Grill SP; Rose WC; Loomis R; Vasquez KM; Cheng Y; Sartorelli AC
    Biochem Pharmacol; 2000 Apr; 59(8):983-91. PubMed ID: 10692563
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Anticancer effect of Howiinol A and its mechanism of action.
    Xu CX; He JH
    J Asian Nat Prod Res; 1999; 2(1):1-19. PubMed ID: 11261201
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tricyclic pyrone analogs: a new class of microtubule-disrupting anticancer drugs effective against murine leukemia cells in vitro.
    Newell SW; Perchellet EM; Ladesich JB; Freeman JA; Chen Y; Liu L; Hua DH; Kraft SL; Basaraba RJ; Perchellet JP
    Int J Oncol; 1998 Feb; 12(2):433-42. PubMed ID: 9458372
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.